Form 8-K - Current report:
SEC Accession No. 0001564590-21-055917
Filing Date
2021-11-10
Accepted
2021-11-10 07:03:11
Documents
40
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-8k_20211110.htm   iXBRL 8-K 39548
2 EX-99.1 stro-ex991_61.htm EX-99.1 248390
3 EX-99.2 stro-ex992_87.htm EX-99.2 27165
4 GRAPHIC slide-pqjhweero0k.jpg GRAPHIC 316276
5 GRAPHIC slide-g2tykhkgsp2.jpg GRAPHIC 152931
6 GRAPHIC slide-jlab5us0vnb.jpg GRAPHIC 325948
7 GRAPHIC slide-hwsd4frezfd.jpg GRAPHIC 222453
8 GRAPHIC slide-ujkhktz11yp.jpg GRAPHIC 205697
9 GRAPHIC slide-adw43efhs1a.jpg GRAPHIC 293991
10 GRAPHIC slide-h41ic0t0edz.jpg GRAPHIC 203075
11 GRAPHIC slide-54bls00fqsb.jpg GRAPHIC 276728
12 GRAPHIC slide-nqqf4kzj0ml.jpg GRAPHIC 220353
13 GRAPHIC slide-sxxqfn4jd3k.jpg GRAPHIC 142494
14 GRAPHIC slide-pcnluoxlx3a.jpg GRAPHIC 322254
15 GRAPHIC slide-kx2k0jdci5f.jpg GRAPHIC 301660
16 GRAPHIC slide-qxejqhjkx1l.jpg GRAPHIC 319088
17 GRAPHIC slide-0nglw3vrdzj.jpg GRAPHIC 297913
18 GRAPHIC slide-tnkm0z21eqn.jpg GRAPHIC 291634
19 GRAPHIC slide-ejgpr4sh1rp.jpg GRAPHIC 199291
20 GRAPHIC slide-ikpzatlwohs.jpg GRAPHIC 227062
21 GRAPHIC slide-fx1nt0uurn3.jpg GRAPHIC 328433
22 GRAPHIC slide-qvj2qq4e3a2.jpg GRAPHIC 302502
23 GRAPHIC slide-s4x4evths0c.jpg GRAPHIC 280559
24 GRAPHIC slide-rgfwfqtualg.jpg GRAPHIC 196718
25 GRAPHIC slide-znjye2klpym.jpg GRAPHIC 156319
26 GRAPHIC slide-m0vbz3oezv3.jpg GRAPHIC 191922
27 GRAPHIC slide-g0tmaogksb5.jpg GRAPHIC 224047
28 GRAPHIC gmtipst5qhn4000001.jpg GRAPHIC 7301
29 GRAPHIC slide-wajcaotomyb.jpg GRAPHIC 446640
  Complete submission text file 0001564590-21-055917.txt   9367690

Data Files

Seq Description Document Type Size
30 XBRL TAXONOMY EXTENSION SCHEMA stro-20211110.xsd EX-101.SCH 5685
31 XBRL TAXONOMY EXTENSION LABEL LINKBASE stro-20211110_lab.xml EX-101.LAB 20078
32 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stro-20211110_pre.xml EX-101.PRE 11934
33 EXTRACTED XBRL INSTANCE DOCUMENT stro-8k_20211110_htm.xml XML 3544
Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 211394349
SIC: 2836 Biological Products, (No Diagnostic Substances)